ABVC Short Long Term Debt vs Total Liab Analysis

ABVC Stock  USD 0.47  0.01  1.06%   
ABVC Biopharma financial indicator trend analysis is way more than just evaluating ABVC Biopharma prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether ABVC Biopharma is a good investment. Please check the relationship between ABVC Biopharma Short Long Term Debt and its Total Liab accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in ABVC Biopharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
For information on how to trade ABVC Stock refer to our How to Trade ABVC Stock guide.

Short Long Term Debt vs Total Liab

Short Long Term Debt vs Total Liab Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of ABVC Biopharma Short Long Term Debt account and Total Liab. At this time, the significance of the direction appears to have strong relationship.
The correlation between ABVC Biopharma's Short Long Term Debt and Total Liab is 0.69. Overlapping area represents the amount of variation of Short Long Term Debt that can explain the historical movement of Total Liab in the same time period over historical financial statements of ABVC Biopharma, assuming nothing else is changed. The correlation between historical values of ABVC Biopharma's Short Long Term Debt and Total Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Short Long Term Debt of ABVC Biopharma are associated (or correlated) with its Total Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Liab has no effect on the direction of Short Long Term Debt i.e., ABVC Biopharma's Short Long Term Debt and Total Liab go up and down completely randomly.

Correlation Coefficient

0.69
Relationship DirectionPositive 
Relationship StrengthSignificant

Short Long Term Debt

The total of a company's short-term and long-term borrowings.

Total Liab

The total amount of all liabilities that a company has, including both short-term and long-term liabilities.
Most indicators from ABVC Biopharma's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into ABVC Biopharma current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in ABVC Biopharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
For information on how to trade ABVC Stock refer to our How to Trade ABVC Stock guide.As of December 11, 2024, Selling General Administrative is expected to decline to about 5 M. In addition to that, Tax Provision is expected to decline to about 217.9 K
 2021 2022 2023 2024 (projected)
Other Operating Expenses11.7M16.1M8.4M4.2M
Total Revenue355.8K969.8K152.4K157.4K

ABVC Biopharma fundamental ratios Correlations

0.640.730.910.22-0.7-0.050.170.50.780.780.680.570.630.63-0.360.490.51-0.460.820.730.780.850.02-0.190.74
0.640.620.40.44-0.3-0.210.58-0.20.310.80.650.810.350.06-0.240.60.6-0.260.690.640.230.40.02-0.30.17
0.730.620.40.61-0.62-0.230.080.370.610.940.320.740.890.48-0.260.140.15-0.20.550.480.580.850.270.180.55
0.910.40.4-0.04-0.630.080.060.560.740.450.640.310.340.65-0.310.480.49-0.510.740.670.770.69-0.11-0.380.75
0.220.440.61-0.04-0.31-0.130.070.20.260.54-0.310.620.40.30.05-0.44-0.44-0.260.01-0.060.280.460.1-0.090.28
-0.7-0.3-0.62-0.63-0.310.2-0.16-0.74-0.99-0.56-0.31-0.38-0.52-0.72-0.16-0.09-0.110.32-0.52-0.53-0.75-0.71-0.330.26-0.74
-0.05-0.21-0.230.08-0.130.2-0.210.08-0.16-0.21-0.06-0.24-0.13-0.06-0.25-0.05-0.05-0.26-0.07-0.040.02-0.030.04-0.160.04
0.170.580.080.060.07-0.16-0.21-0.410.130.340.440.26-0.11-0.130.420.530.53-0.130.210.24-0.06-0.080.0-0.17-0.08
0.5-0.20.370.560.2-0.740.08-0.410.770.19-0.07-0.040.470.76-0.05-0.33-0.31-0.210.250.220.740.680.2-0.080.76
0.780.310.610.740.26-0.99-0.160.130.770.570.370.370.520.770.080.150.16-0.390.570.560.810.760.25-0.290.8
0.780.80.940.450.54-0.56-0.210.340.190.570.510.740.820.4-0.310.370.38-0.220.640.570.540.790.250.090.5
0.680.650.320.64-0.31-0.31-0.060.44-0.070.370.510.410.22-0.02-0.30.950.96-0.240.880.880.190.260.0-0.220.13
0.570.810.740.310.62-0.38-0.240.26-0.040.370.740.410.380.11-0.090.290.29-0.420.580.560.210.45-0.01-0.230.18
0.630.350.890.340.4-0.52-0.13-0.110.470.520.820.220.380.52-0.450.050.060.020.410.320.620.860.370.430.59
0.630.060.480.650.3-0.72-0.06-0.130.760.770.4-0.020.110.52-0.07-0.16-0.15-0.230.180.10.960.810.23-0.140.98
-0.36-0.24-0.26-0.310.05-0.16-0.250.42-0.050.08-0.31-0.3-0.09-0.45-0.07-0.26-0.26-0.03-0.37-0.27-0.23-0.36-0.04-0.09-0.19
0.490.60.140.48-0.44-0.09-0.050.53-0.330.150.370.950.290.05-0.16-0.261.0-0.150.70.710.030.05-0.05-0.17-0.02
0.510.60.150.49-0.44-0.11-0.050.53-0.310.160.380.960.290.06-0.15-0.261.0-0.160.710.720.040.07-0.04-0.18-0.01
-0.46-0.26-0.2-0.51-0.260.32-0.26-0.13-0.21-0.39-0.22-0.24-0.420.02-0.23-0.03-0.15-0.16-0.29-0.27-0.27-0.280.460.29-0.27
0.820.690.550.740.01-0.52-0.070.210.250.570.640.880.580.410.18-0.370.70.71-0.290.980.390.510.11-0.310.33
0.730.640.480.67-0.06-0.53-0.040.240.220.560.570.880.560.320.1-0.270.710.72-0.270.980.310.40.19-0.370.25
0.780.230.580.770.28-0.750.02-0.060.740.810.540.190.210.620.96-0.230.030.04-0.270.390.310.90.27-0.181.0
0.850.40.850.690.46-0.71-0.03-0.080.680.760.790.260.450.860.81-0.360.050.07-0.280.510.40.90.210.070.88
0.020.020.27-0.110.1-0.330.040.00.20.250.250.0-0.010.370.23-0.04-0.05-0.040.460.110.190.270.21-0.10.26
-0.19-0.30.18-0.38-0.090.26-0.16-0.17-0.08-0.290.09-0.22-0.230.43-0.14-0.09-0.17-0.180.29-0.31-0.37-0.180.07-0.1-0.18
0.740.170.550.750.28-0.740.04-0.080.760.80.50.130.180.590.98-0.19-0.02-0.01-0.270.330.251.00.880.26-0.18
Click cells to compare fundamentals

ABVC Biopharma Account Relationship Matchups

ABVC Biopharma fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets6.9M11.6M13.7M9.9M14.5M15.2M
Short Long Term Debt Total4.6M6.5M3.1M3.1M2.3M1.9M
Total Current Liabilities6.8M4.8M3.7M5.8M5.9M6.2M
Total Stockholder Equity(151.0K)3.4M8.8M3.1M8.4M8.8M
Net Debt4.4M2.2M(2.7M)3.0M2.2M2.3M
Retained Earnings(15.9M)(25.6M)(38.5M)(54.9M)(65.4M)(62.1M)
Common Stock Shares Outstanding1.7M2.0M2.5M3.2M4.3M4.6M
Liabilities And Stockholders Equity6.9M11.6M13.7M9.9M14.5M15.2M
Non Current Liabilities Total238.4K4.1M1.1M420.2K429.1K407.7K
Inventory(477.0K)(839.7K)26.0K1.3M1.5M1.6M
Other Stockholder Equity15.0M28.5M46.8M57.5M73.3M76.9M
Total Liab7.1M8.9M4.8M6.2M6.4M6.7M
Total Current Assets878.2K6.2M9.6M3.0M1.7M1.4M
Short Term Debt4.3M2.4M2.0M2.3M1.9M1.3M
Other Current Liab2.4M2.4M1.7M3.3M3.9M4.1M
Cash144.3K4.3M5.8M85.3K60.2K57.1K
Cash And Short Term Investments144.3K4.3M5.9M161.1K139.5K132.5K
Common Stock19.5K24.4K28.9K32.9K7.9K7.5K
Net Receivables640.5K999.4K1.7M1.4M759.6K625.0K
Other Current Assets570.4K900.4K1.9M1.5M757.7K388.3K
Non Current Assets Total6.0M5.4M4.1M6.9M12.8M13.5M
Non Currrent Assets Other179.5K164.8K160.5K1.3M1.5M1.6M
Common Stock Total Equity213.7K213.9K19.5K24.4K28.1K26.7K
Accumulated Other Comprehensive Income663.8K564.9K539.7K517.1K516.4K396.8K
Net Tangible Assets(5.7M)(151.0K)3.4M8.8M10.2M10.7M
Other Assets1.4M1.6M2.0M1.1M1.3M1.4M
Short Long Term Debt4.0M2.1M1.8M1.9M1.5M2.0M
Other Liab27.5K2.9K19.3K10.6K12.2K11.0K
Short Term Investments3.4M1.2M108.1K75.8K79.3K75.3K
Long Term Investments3.4M1.2M932.8K842.1K2.5M1.8M
Property Plant Equipment510.1K1.0M2.3M2.0M2.3M2.4M
Net Invested Capital3.9M8.1M10.7M5.0M9.9M10.3M
Net Working Capital(5.9M)1.3M5.9M(2.8M)(4.3M)(4.1M)
Capital Stock19.5K24.4K28.9K32.9K7.9K7.5K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether ABVC Biopharma offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ABVC Biopharma's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Abvc Biopharma Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Abvc Biopharma Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in ABVC Biopharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
For information on how to trade ABVC Stock refer to our How to Trade ABVC Stock guide.
You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ABVC Biopharma. If investors know ABVC will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ABVC Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.81)
Revenue Per Share
0.017
Quarterly Revenue Growth
18.175
Return On Assets
(0.45)
Return On Equity
(3.20)
The market value of ABVC Biopharma is measured differently than its book value, which is the value of ABVC that is recorded on the company's balance sheet. Investors also form their own opinion of ABVC Biopharma's value that differs from its market value or its book value, called intrinsic value, which is ABVC Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ABVC Biopharma's market value can be influenced by many factors that don't directly affect ABVC Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ABVC Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if ABVC Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ABVC Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.